Linden Thomas Advisory Services, LLC

Position in AMGN — Amgen Inc

CIK 1965702 Charlotte, NC

Position in AMGN

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$3,028,771

+$164,712 QoQ

Shares Held

8,364

+2.8% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.25%

of 13F equity value

Holder Rank

#1,078

of 3,140 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Linden Thomas Advisory Services, LLC holds $22,830,139 across 6 Drug Manufacturers - General names. AMGN ranks #5 (13.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	6,333	$7,595,990
2	ABBV	AbbVie Inc.	15,041	$3,784,917
3	GILD	Gilead Sciences, Inc.	27,150	$3,430,131
4	MRK	Merck & Co., Inc.	25,106	$3,226,121
5	AMGN	Amgen Inc This page	8,364	$3,028,771
6	BMY	Bristol Myers Squibb Co	30,618	$1,764,209

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,028,771	8,364	+2.8%	Shares	Sole	2026-07-16
2026-03-31	$2,864,059	8,140	+2.7%	Shares	Sole	2026-04-10
2025-12-31	$2,594,586	7,927	+3.3%	Shares	Sole	2026-01-16
2025-09-30	$2,165,038	7,672	+3.5%	Shares	Sole	2025-11-06
2025-06-30	$2,070,342	7,415	+4.2%	Shares	Sole	2025-07-31
2025-03-31	$2,216,678	7,115	+0.7%	Shares	Sole	2025-04-30
2024-12-31	$1,840,900	7,063	-0.4%	Shares	Sole	2025-01-21
2024-09-30	$2,284,791	7,091	-0.3%	Shares	Sole	2024-10-17
2024-06-30	$2,223,081	7,115	-1.4%	Shares	Sole	2024-07-10
2024-03-31	$2,051,084	7,214	+0.6%	Shares	Sole	2024-04-30
2023-12-31	$2,064,527	7,168	+4.5%	Shares	Sole	2024-02-01
2023-09-30	$1,843,962	6,861	+1.5%	Shares	Sole	2023-10-20
2023-06-30	$1,501,077	6,761	+2.8%	Shares	Sole	2023-07-27
2023-03-31	$1,589,264	6,574	+11.0%	Shares	Sole	2023-04-25
2022-12-31	$1,555,879	5,924	—	Shares	Sole	2023-02-17
No filing history on record for this holder in this stock.